High expression of FAP has been proved to be related to a poor prognosis in pancreatic ductal adenocarcinoma (32), colorectal cancer (17) and gastric cancer (16, 18, 33), but none of their patients underwent NCT. The gene discussed is FAP; the disease is pancreatic ductal adenocarcinoma.